Darlene B. Royce

2.1k total citations
39 papers, 1.7k citations indexed

About

Darlene B. Royce is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Darlene B. Royce has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Genetics. Recurrent topics in Darlene B. Royce's work include Genomics, phytochemicals, and oxidative stress (12 papers), Multiple Sclerosis Research Studies (6 papers) and Estrogen and related hormone effects (6 papers). Darlene B. Royce is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (12 papers), Multiple Sclerosis Research Studies (6 papers) and Estrogen and related hormone effects (6 papers). Darlene B. Royce collaborates with scholars based in United States, United Kingdom and Italy. Darlene B. Royce's co-authors include Karen T. Liby, Michael B. Sporn, Charlotte R. Williams, Renee Risingsong, Gordon W. Gribble, Tadashi Honda, Mark M. Yore, Nanjoo Suh, Francesca Gilli and Andrew R. Pachner and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Darlene B. Royce

39 papers receiving 1.7k citations

Peers

Darlene B. Royce

ONCOL

IMMUN

GENET

Tingfang Yi United States

Tatyana A. Zykova United States

Sung‐Gook Cho South Korea

Yinxue Yang China

Ke Yao United States

Julian C. Desmond United States

Dong Joon Kim China

Xianzhong Ding United States

John P. Alao Sweden

ShouWei Han United States

Tingfang Yi United States

Darlene B. Royce

1.0k ×0.8

281 ×1.0

ONCOL

141 ×0.7

IMMUN

221 ×1.2

103 ×0.6

GENET

Citations per year, relative to Darlene B. Royce Darlene B. Royce (= 1×) peers Tingfang Yi

Countries citing papers authored by Darlene B. Royce

Since Specialization

Citations

This map shows the geographic impact of Darlene B. Royce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darlene B. Royce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darlene B. Royce more than expected).

Fields of papers citing papers by Darlene B. Royce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darlene B. Royce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darlene B. Royce. The network helps show where Darlene B. Royce may publish in the future.

Co-authorship network of co-authors of Darlene B. Royce

This figure shows the co-authorship network connecting the top 25 collaborators of Darlene B. Royce. A scholar is included among the top collaborators of Darlene B. Royce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darlene B. Royce. Darlene B. Royce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verster, Adrian J., et al.. (2023). Community composition and the environment modulate the population dynamics of type VI secretion in human gut bacteria. Nature Ecology & Evolution. 7(12). 2092–2107. 18 indexed citations

DiSano, Krista D., et al.. (2019). Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis. Journal of Neuroinflammation. 16(1). 109–109. 17 indexed citations

DiSano, Krista D., Darlene B. Royce, Francesca Gilli, & Andrew R. Pachner. (2019). Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis. Frontiers in Immunology. 10. 1821–1821. 25 indexed citations

Gilli, Francesca, et al.. (2019). Quantitative Measurement of Intrathecally Synthesized Proteins in Mice. Journal of Visualized Experiments. 1 indexed citations

Gilli, Francesca, et al.. (2018). Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta. International Immunopharmacology. 62. 1–6. 3 indexed citations

Gilli, Francesca, Libin Li, Darlene B. Royce, Krista D. DiSano, & Andrew R. Pachner. (2017). Treatment of Theiler’s virus-induced demyelinating disease with teriflunomide. Journal of NeuroVirology. 23(6). 825–838. 17 indexed citations

Gilli, Francesca, Darlene B. Royce, Krista D. DiSano, & Andrew R. Pachner. (2017). Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis. Journal of Neuroimmunology. 313. 34–40. 4 indexed citations

Leal, Ana S., Charlotte R. Williams, Darlene B. Royce, et al.. (2017). Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Cancer Letters. 394. 76–87. 96 indexed citations

Kumar, Rajiv, Paige Baldwin, Ana S. Leal, et al.. (2017). Sustained Release Talazoparib Implants for Localized Treatment of BRCA1-deficient Breast Cancer. Theranostics. 7(17). 4340–4349. 26 indexed citations

10.

Gilli, Francesca, Darlene B. Royce, & Andrew R. Pachner. (2016). Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis. Journal of Visualized Experiments. 16 indexed citations

11.

Royce, Darlene B., et al.. (2015). The Rexinoids LG100268 and LG101506 Inhibit Inflammation and Suppress Lung Carcinogenesis in A/J Mice. Cancer Prevention Research. 9(1). 105–114. 19 indexed citations

12.

To, Ciric, Carol S. Ringelberg, Darlene B. Royce, et al.. (2015). Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis. Carcinogenesis. 36(7). 769–781. 60 indexed citations

13.

Williams, Charlotte R., et al.. (2015). Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention. Pharmacological Research. 100. 135–147. 26 indexed citations

14.

Tran, Kim‐Vy, Renee Risingsong, Darlene B. Royce, et al.. (2012). The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor–Negative Mammary Carcinogenesis in Polyoma Middle T Mice. Cancer Prevention Research. 5(5). 726–734. 40 indexed citations

15.

Risingsong, Renee, Darlene B. Royce, Charlotte R. Williams, et al.. (2012). The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer. Carcinogenesis. 34(1). 199–210. 40 indexed citations

16.

Liby, Karen T., Darlene B. Royce, Renee Risingsong, et al.. (2010). Synthetic Triterpenoids Prolong Survival in a Transgenic Mouse Model of Pancreatic Cancer. Cancer Prevention Research. 3(11). 1427–1434. 78 indexed citations

17.

Liby, Karen T., Renee Risingsong, Darlene B. Royce, et al.. (2008). Prevention and Treatment of Experimental Estrogen Receptor–Negative Mammary Carcinogenesis by the Synthetic Triterpenoid CDDO-Methyl Ester and the Rexinoid LG100268. Clinical Cancer Research. 14(14). 4556–4563. 66 indexed citations

18.

Liby, Karen T., Darlene B. Royce, Renee Risingsong, et al.. (2006). The triterpenoid, CDDO-methyl ester, and the rexinoid, LG100268, synergize in the prevention of mammary tumors in a mouse model of estrogen receptor-negative breast cancer.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

19.

Honda, Tadashi, Karen T. Liby, Chitra Sundararajan, et al.. (2006). Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A. Bioorganic & Medicinal Chemistry Letters. 16(24). 6306–6309. 40 indexed citations

20.

Liby, Karen T., Thomas Hock, Mark M. Yore, et al.. (2005). The Synthetic Triterpenoids, CDDO and CDDO-Imidazolide, Are Potent Inducers of Heme Oxygenase-1 and Nrf2/ARE Signaling. Cancer Research. 65(11). 4789–4798. 239 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact